network member

Nebraska Cancer Specialists

Nebraska Cancer Specialists

About Network Member

Nebraska Cancer Specialists is dedicated to providing complete treatment for patients, medical oncology, radiation oncology, surgical specialists and diagnostic services. Experience you can trust. Compassion you can feel. When facing cancer, choosing the right facility is one of the most important decisions you can make. The physicians at Nebraska Cancer Specialists are some of the most experienced and highly qualified in the area. Along with our caring staff, our warm and inviting atmosphere helps you and your family members manage cancer treatment in comfort. Nebraska Cancer Specialists is the regional leader in cancer diagnosis, treatment and research. We provide considerate, state-of-the-art care for our patients, including: – Imaging/diagnostic equipment, chemotherapy, radiation oncology, and surgical and support services – More than 100 clinical trials available – Oncology- and chemotherapy-certified nurses – Easy accessibility with five metro Omaha locations Diagnostic services: – CT scans – PET scans – Nuclear camera/bone scans – X-rays Additional services provided at the Midwest Cancer Center – Legacy: – Genetic counseling – Lymphedema management – Psychosocial care – Social workers – Nurse navigators – Lyle McCaig image recovery services – Radiology Nebraska Cancer Specialists is one of the healthcare providers in the Midwest that is leading the way in personalized cancer care. Personalized cancer care is based on the concept that each person’s cancer is unique. Treatment that works for one person may be completely ineffective for the other person. With personalized cancer care we may be able to identify of the right biomarker or “target” associated with a person’s unique cancer and create a personalized a treatment plan tailored to each patient. Learn more. History Nebraska Cancer Specialists is a subspecialty practice of 13 collaborating physicians who are devoted to oncology (tumors and cancer) and hematology (diseases of the blood and blood-forming organs). We are committed to providing you with the state of the art medical treatment and compassionate care in our outpatient offices and hospital settings Website: Nebraska Cancer Specialists
Megan Meays, M.A.M CCRC
Enrollment Closed

HCRN-MEL16-252

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252
Cancer areas:Melanoma
Fox Chase Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Nebraska Cancer Specialists
Providence Cancer Institute
University of Iowa Holden Comprehensive Cancer Center